Report Detail
Global (United States, European Union and China) Venous thromboembolism(VTE)Therapeutics Market Research Report 2019-2025
- RnM3670316 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Other
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot that occurs only in the veins; generally, they occur in the deep veins of the legs and pelvis, but may also occur in the veins of the upper body (AHA, 2017; Cohen et al., 2007; Heit, 2015). The clot may break off from its original location and travel throughout the circulatory system, and if the clot ends up in the lung, it is known as a PE
One of the Major drivers of VTE market growth over the forecast period is the increase in patient shares towards the NOACs due to increased confidence among physicians about using these novel therapies.
In 2019, the market size of Venous thromboembolism(VTE)Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Venous thromboembolism(VTE)Therapeutics.
This report studies the global market size of Venous thromboembolism(VTE)Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Venous thromboembolism(VTE)Therapeutics production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Boehringer Ingelheim
Bayer
Janssen
Bristol-Myers Squibb
Pfizer
Daiichi-Sankyo
Portola Pharmaceuticals
Armetheon
Market Segment by Product Type
Deep Vein Thrombosis(DVT)
Pulmonary Embolism(PE)
Others
Market Segment by Application
Hospital
ASCs
Research Institutes
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Venous thromboembolism(VTE)Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Venous thromboembolism(VTE)Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Venous thromboembolism(VTE)Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Venous thromboembolism(VTE)Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Deep Vein Thrombosis(DVT)
- 1.3.3 Pulmonary Embolism(PE)
- 1.3.4 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Venous thromboembolism(VTE)Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 ASCs
- 1.4.4 Research Institutes
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Venous thromboembolism(VTE)Therapeutics Production Value 2014-2025
- 2.1.2 Global Venous thromboembolism(VTE)Therapeutics Production 2014-2025
- 2.1.3 Global Venous thromboembolism(VTE)Therapeutics Capacity 2014-2025
- 2.1.4 Global Venous thromboembolism(VTE)Therapeutics Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Venous thromboembolism(VTE)Therapeutics Market Size CAGR of Key Regions
- 2.2.2 Global Venous thromboembolism(VTE)Therapeutics Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Venous thromboembolism(VTE)Therapeutics Capacity by Manufacturers
- 3.1.2 Global Venous thromboembolism(VTE)Therapeutics Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Venous thromboembolism(VTE)Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Venous thromboembolism(VTE)Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Venous thromboembolism(VTE)Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Venous thromboembolism(VTE)Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Venous thromboembolism(VTE)Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Venous thromboembolism(VTE)Therapeutics Market
- 3.6 Key Manufacturers Venous thromboembolism(VTE)Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Deep Vein Thrombosis(DVT) Production and Production Value (2014-2019)
- 4.1.2 Pulmonary Embolism(PE) Production and Production Value (2014-2019)
- 4.1.3 Others Production and Production Value (2014-2019)
- 4.2 Global Venous thromboembolism(VTE)Therapeutics Production Market Share by Type
- 4.3 Global Venous thromboembolism(VTE)Therapeutics Production Value Market Share by Type
- 4.4 Venous thromboembolism(VTE)Therapeutics Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Venous thromboembolism(VTE)Therapeutics Consumption by Application
6 Production by Regions
- 6.1 Global Venous thromboembolism(VTE)Therapeutics Production (History Data) by Regions 2014-2019
- 6.2 Global Venous thromboembolism(VTE)Therapeutics Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Venous thromboembolism(VTE)Therapeutics Production Growth Rate 2014-2019
- 6.3.2 United States Venous thromboembolism(VTE)Therapeutics Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Venous thromboembolism(VTE)Therapeutics Import & Export
- 6.4 European Union
- 6.4.1 European Union Venous thromboembolism(VTE)Therapeutics Production Growth Rate 2014-2019
- 6.4.2 European Union Venous thromboembolism(VTE)Therapeutics Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Venous thromboembolism(VTE)Therapeutics Import & Export
- 6.5 China
- 6.5.1 China Venous thromboembolism(VTE)Therapeutics Production Growth Rate 2014-2019
- 6.5.2 China Venous thromboembolism(VTE)Therapeutics Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Venous thromboembolism(VTE)Therapeutics Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Venous thromboembolism(VTE)Therapeutics Consumption by Regions
- 7.1 Global Venous thromboembolism(VTE)Therapeutics Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Venous thromboembolism(VTE)Therapeutics Consumption by Type
- 7.2.2 United States Venous thromboembolism(VTE)Therapeutics Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Venous thromboembolism(VTE)Therapeutics Consumption by Type
- 7.3.2 European Union Venous thromboembolism(VTE)Therapeutics Consumption by Application
- 7.4 China
- 7.4.1 China Venous thromboembolism(VTE)Therapeutics Consumption by Type
- 7.4.2 China Venous thromboembolism(VTE)Therapeutics Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Venous thromboembolism(VTE)Therapeutics Consumption by Type
- 7.5.2 Rest of World Venous thromboembolism(VTE)Therapeutics Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Boehringer Ingelheim
- 8.1.1 Boehringer Ingelheim Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Venous thromboembolism(VTE)Therapeutics
- 8.1.4 Venous thromboembolism(VTE)Therapeutics Product Introduction
- 8.1.5 Boehringer Ingelheim Recent Development
- 8.2 Bayer
- 8.2.1 Bayer Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Venous thromboembolism(VTE)Therapeutics
- 8.2.4 Venous thromboembolism(VTE)Therapeutics Product Introduction
- 8.2.5 Bayer Recent Development
- 8.3 Janssen
- 8.3.1 Janssen Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Venous thromboembolism(VTE)Therapeutics
- 8.3.4 Venous thromboembolism(VTE)Therapeutics Product Introduction
- 8.3.5 Janssen Recent Development
- 8.4 Bristol-Myers Squibb
- 8.4.1 Bristol-Myers Squibb Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Venous thromboembolism(VTE)Therapeutics
- 8.4.4 Venous thromboembolism(VTE)Therapeutics Product Introduction
- 8.4.5 Bristol-Myers Squibb Recent Development
- 8.5 Pfizer
- 8.5.1 Pfizer Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Venous thromboembolism(VTE)Therapeutics
- 8.5.4 Venous thromboembolism(VTE)Therapeutics Product Introduction
- 8.5.5 Pfizer Recent Development
- 8.6 Daiichi-Sankyo
- 8.6.1 Daiichi-Sankyo Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Venous thromboembolism(VTE)Therapeutics
- 8.6.4 Venous thromboembolism(VTE)Therapeutics Product Introduction
- 8.6.5 Daiichi-Sankyo Recent Development
- 8.7 Portola Pharmaceuticals
- 8.7.1 Portola Pharmaceuticals Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Venous thromboembolism(VTE)Therapeutics
- 8.7.4 Venous thromboembolism(VTE)Therapeutics Product Introduction
- 8.7.5 Portola Pharmaceuticals Recent Development
- 8.8 Armetheon
- 8.8.1 Armetheon Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Venous thromboembolism(VTE)Therapeutics
- 8.8.4 Venous thromboembolism(VTE)Therapeutics Product Introduction
- 8.8.5 Armetheon Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Venous thromboembolism(VTE)Therapeutics Capacity, Production Forecast 2019-2025
- 9.1.2 Global Venous thromboembolism(VTE)Therapeutics Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Venous thromboembolism(VTE)Therapeutics Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Venous thromboembolism(VTE)Therapeutics Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Venous thromboembolism(VTE)Therapeutics Production Forecast by Type
- 9.7.2 Global Venous thromboembolism(VTE)Therapeutics Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Venous thromboembolism(VTE)Therapeutics Sales Channels
- 10.2.2 Venous thromboembolism(VTE)Therapeutics Distributors
- 10.3 Venous thromboembolism(VTE)Therapeutics Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Venous thromboembolism(VTE)Therapeutics. Industry analysis & Market Report on Venous thromboembolism(VTE)Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Venous thromboembolism(VTE)Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Venous thromboembolism(VTE)Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
